poisar

Stocks · News reference

Health Catalyst Reports Q2 2026 Results: Full Earnings Call Transcript

Benzinga Insights

Health Catalyst (NASDAQ:HCAT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

HCAT
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Researchandmarkets.Com

    Europe Clinical Data Analytics Market Outlook 2026-2033 | AI, Cloud Deployment and Data-Driven Healthcare Adoption Accelerate Across the Region

    Europe's clinical data analytics market is projected to reach USD 105.6 billion by 2031, growing at a 27% CAGR through 2033. Growth is driven by healthcare digitalization, AI adoption, cloud deployment, and regulatory initiatives like the European Health Data Space. Software and cloud-based solutions lead the market, with healthcare providers and payers increasingly investing in analytics for improved patient outcomes and operational efficiency.

    UNHORCLORCLPDIQVDASTY
  2. Na

    Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    Health Catalyst, Inc. announced the appointment of Simeon Kohl as Chief Executive Officer and President effective September 14, 2026. As part of his employment inducement, Kohl was granted 2,747,385 restricted stock units vesting over approximately two years, with the first tranche of 915,975 RSUs vesting after one year. Kohl also purchased 59,000 shares of Health Catalyst common stock through open market purchases.

    HCAT
  3. SEC EDGAR

    8-K filing — Health Catalyst, Inc. (HCAT)

    Filed: 2026-09-14 AccNo: 0001636422-26-000111 Size: 205 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    HCAT